Subscribe to our Newsletters !!

    Kumar Jeetendra

    AFYS3G Automation compatible recapper for screw cap tubes

    Designed to improve efficiency, the AFYS3G Recapper for Screw Cap Tubes can be used as a stand-alone instrument or be simply integrated into a fully automated laboratory environment. This makes the recapper ideal for high throughput workflows, to scale-up sample processing for (COVID-19) testing or research, and to relieve researchers from repetitive manual labor. The

    AI calculations help anticipate out-of-emergency clinic heart failure endurance

    Using neighborhood and neighborhood data in combination with existing data sources creates a more precise prediction on a patient’s recovery prospects after an out-of-hospital cardiac arrest (OHCA), according to preliminary study to be presented in the American Heart Association’s Resuscitation Science Symposium 2020. The 2020 meeting will be held virtually, November 14-16, and will feature

    Repositive expands global cancer model network with CRO from Finland

    CAMBRIDGE, UK – (November 10, 2020) – Life Science Newswire – Repositive, the world’s largest directory of preclinical cancer models, has expanded its global network of contract research organisation (CRO) partners with the addition of Pharmatest, a CRO providing clinically predictive preclinical efficacy services for oncology and skeletal diseases. Pharmatest brings to the partnership more

    Cell Guidance Systems launches Exo-spin 96 kit for exosomes purification

    Cell Guidance Systems Ltda specialist in exosome study reagents and services, today announced the launching of a brand new product for the purification of exosomes from blood and other samples. The Exo-spin™ 96 exosome purification kit allows researchers to purify exosome samples in the standard 96 well plate format. The Exo-spin 96 kit is based

    Singapore working on making sure about arrangement of COVID-19 vaccines

    Singapore will work towards procuring a”portfolio” of all COVID-19 vaccines to appeal to various parts of the populace instead of relying upon a single vaccine,” Health Minister Gan Kim Yong said on November 10. Speaking during a digital media conference by the multi-ministry job force on COVID-19, Gan said that the application of a vaccine

    Glenmark Pharma gets USFDA gesture for Tacrolimus capsules

    Tacrolimus capsule is an immunosuppressant and can be employed for preventing organ rejection in certain patients after kidney, liver, or heart transplant. Glenmark Pharmaceuticals Inc, USA, has been granted final approval by the United States Food and Drug Administration (USFDA) for Tacrolimus Capsules USP in the strengths of 0.5 mg, 1 mg and 5 mg,

    Russia says its Sputnik V COVID-19 immunization is 92% successful

    Russia’s Sputnik V vaccine is 92% effective at protecting people from COVID-19 based on interim trial results, the nation’s sovereign wealth fund said on Wednesday, as Moscow rushes to maintain pace with Western drugmakers in the race to get a shot. The first results are only the next to be released from a late-stage human

    Microorganisms in the lungs could impact lung cancer progression and prognosis

    Bottom Line: Enrichment of the lungs with oral commensal microbes has been correlated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer. Journal in Which the research was Published: Cancer Discovery, a journal of the American Association for Cancer Research Author: Leopoldo Segal, MD, director of the Lung Microbiome Program,

    Isohelix and Precision Genetics Partner to Expand COVID-19 Testing Using Saliva Collection Technology

    HARRIETSHAM, UK – (November 12, 2020) – Life Science Newswire – Isohelix, a specialist provider of DNA and RNA sampling and purification products, announced that its state-of-the-art GeneFiX™ Saliva RNA Collection Device is the technology of choice for COVID-19 testing by Precision Genetics, a leading healthcare technology company and high capacity molecular testing laboratory. The

    Pioneering research detects Hormone-Upregulated lncRNA within the lymphocyte-specific protein tyrosine kinase (HULLK) discovered in Prostate Cancer

    Manchester, UK and Virginia, USA – 12th November 2020 – Life Science Newswire – Pioneering research conducted by University of Virginia in collaboration with Manchester UK based APIS Assay Technologies Ltd has discovered Hormone-Upregulated lncRNA within the lymphocyte-specific protein tyrosine kinase (HULLK) is detectable in non-invasive prostate cancer patient samples. The breakthrough data provides a